Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system
- 15 May 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (10), 2650-2653
- https://doi.org/10.1016/j.bmcl.2009.03.145
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antibody-Drug Conjugates for Cancer TherapyThe Cancer Journal, 2008
- Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug ConjugatesCancer Research, 2006
- Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and ToxicityBioconjugate Chemistry, 2005
- Dipeptide-based highly potent doxorubicin antibody conjugatesBioorganic & Medicinal Chemistry Letters, 2005
- Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder ConjugatesJournal of Medicinal Chemistry, 2005
- cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activityBlood, 2003
- Development of potent monoclonal antibody auristatin conjugates for cancer therapyNature Biotechnology, 2003
- Synthesis and evaluation of antiproliferative activity of a geldanamycin–Herceptin™ immunoconjugateBioorganic & Medicinal Chemistry Letters, 2000
- erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationshipsJournal of Medicinal Chemistry, 1995
- Selective killing of tumor cells in vitro by immunotoxin composed of antitumor antibiotic streptonigrin and polyclonal specific antibodiesInternational Journal of Immunopharmacology, 1994